芪丹化瘀方治疗缺血性中风恢复期气虚血瘀证的临床疗效观察

《芪丹化瘀方治疗缺血性中风恢复期气虚血瘀证的临床疗效观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、提要目的：探讨芪丹化瘀方治疗缺血性中风气虚血瘀证的临床疗效和机理。方法：临床研究共收集病例60例，疗程为28天。按随机法分为芪丹化瘀方组30例，脑心通组30例，观察其对缺血性中风患者神经缺损评分、日常生活能力积分及中医气虚血瘀证证候积分的变化，并进行血液流变学观察、血清超敏C反应蛋白。结果：临床研究表明：芪丹化瘀方能明显降低缺血性中风患者神经缺损评分、提高日常生活能力，明显减轻气虚血瘀证证候积分，改善血液流变学指标，降低血清C反应蛋白浓度。结论：1.芪丹化瘀方对缺血性中风恢复期气虚血瘀证具有较好的治疗

2、效果。2.芪丹化瘀方能改善患者神经功能缺损评分、提高日常生活能力，明显减轻气虚血瘀证证候积分，其神经保护作用可能与降低血清C反应蛋白含量，从而减轻炎症损伤、保护血管内皮细胞有关。关键词缺血性中风；气虚血瘀证；芪丹化瘀方；临床观察TheObservationofclinicaleffectofQidanHuayuFangintreatingRecoverystageofCerebralInfarctionSpeciality：InternalMedicineofTCM.Author：WangFengme

3、ngTutor：ProfLiChangShengAbstractObjective：Tostudythecurativeeffectofrecoverystageofischemicapoplexywithqi-insufficicncyandbloodstasistreatedbyQidanHuayuFang(QDHYF).Meyhods:Weselected30casesrecoverystageofischemicapoplexypatients,takenofQDHYF,comparingwi

4、th30casesoftakingnaoxintongcapsule,observingtheneurologicaldeficitscoreandabilityofdailylifeandsyndromesqi-insufficicncyandbloodstasisofTCM,changesofbloodandplasmaviscosity,thelevelofbloodCRP.Results：QDHYFcanrelieveobviouslyneurologicaldeficitscore,impr

5、oveabilityofdailylife,relievethescoreofsyndromeqi-insufficicncyandbloodstasis,decreasebloodandplasmaviscosity,decreasebloodCRP.Conclusion：1.QDHYFisobviouslyeffectiveontreatmentofrecoverystageofCerebralInfarctionwithsyndromeqi-insufficicncyandbloodstasis

6、.2.QDHYFcanrelieveobviouslyneurologicaldeficitscore,improveabilityofdailylife,relievethescoreofsyndromeqi-insufficicncyandbloodstasis,decreasebloodandplasmaviscosity,reducedbloodCRPlevelalso.KeywordCerebralInfarction;QidanHuayuFang;Syndromeqi-insufficie

7、ncyandbloodstasis;clinicalobservation目录引言...............................................................................................................................1临床研究................................................................................

8、...............................................21病例选择............................................................................................................................21.1病例来源............................................